US Patent 10167291 | Patents | Expiry | Expiration | Dates

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10167291

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-07-01

Patent Use Code

U-2145

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10167291

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-07-01

Patent Use Code

U-2671

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10167291

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-07-01

Patent Use Code

U-2669

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10167291

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-07-01

Patent Use Code

U-2668

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10167291

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-07-01

Patent Use Code

U-2666

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10167291

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-07-01

Patent Use Code

U-2670

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10167291

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-07-01

Patent Use Code

U-2667

Delist Requested

Application Number

210259

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10167291

Y

2036-07-01

U-2145

1

Y

2036-07-01

U-2671

1

Y

2036-07-01

U-2669

1

Y

2036-07-01

U-2668

1

Y

2036-07-01

U-2666

1

Y

2036-07-01

U-2670

1

Y

2036-07-01

U-2667

1